Literature DB >> 33441440

The Role of the HLA Class I α2 Helix in Determining Ligand Hierarchy for the Killer Cell Ig-like Receptor 3DL1.

Philippa M Saunders1, Bruce J MacLachlan2, Jacqueline Widjaja3, Shu Cheng Wong3, Clare V L Oates3, Jamie Rossjohn2,4,5, Julian P Vivian2,4, Andrew G Brooks1.   

Abstract

HLA class I molecules that represent ligands for the inhibitory killer cell Ig-like receptor (KIR) 3DL1 found on NK cells are categorically defined as those HLA-A and HLA-B allotypes containing the Bw4 motif, yet KIR3DL1 demonstrates hierarchical recognition of these HLA-Bw4 ligands. To better understand the molecular basis underpinning differential KIR3DL1 recognition, the HLA-ABw4 family of allotypes were investigated. Transfected human 721.221 cells expressing HLA-A*32:01 strongly inhibited primary human KIR3DL1+ NK cells, whereas HLA-A*24:02 and HLA-A*23:01 displayed intermediate potency and HLA-A*25:01 failed to inhibit activation of KIR3DL1+ NK cells. Structural studies demonstrated that recognition of HLA-A*24:02 by KIR3DL1 used identical contacts as the potent HLA-B*57:01 ligand. Namely, the D1-D2 domains of KIR3DL1 were placed over the α1 helix and α2 helix of the HLA-A*24:02 binding cleft, respectively, whereas the D0 domain contacted the side of the HLA-A*24:02 molecule. Nevertheless, functional analyses showed KIR3DL1 recognition of HLA-A*24:02 was more sensitive to substitutions within the α2 helix of HLA-A*24:02, including residues Ile142 and Lys144 Furthermore, the presence of Thr149 in the α2 helix of HLA-A*25:01 abrogated KIR3DL1+ NK inhibition. Together, these data demonstrate a role for the HLA class I α2 helix in determining the hierarchy of KIR3DL1 ligands. Thus, recognition of HLA class I is dependent on a complex interplay between the peptide repertoire, polymorphisms within and proximal to the Bw4 motif, and the α2 helix. Collectively, the data furthers our understanding of KIR3DL1 ligands and will inform genetic association and immunogenetics studies examining the role of KIR3DL1 in disease settings.
Copyright © 2021 by The American Association of Immunologists, Inc.

Entities:  

Year:  2021        PMID: 33441440     DOI: 10.4049/jimmunol.2001109

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  High-Resolution Analysis Identifies High Frequency of KIR-A Haplotypes and Inhibitory Interactions of KIR With HLA Class I in Zhejiang Han.

Authors:  Sudan Tao; Yanmin He; Katherine M Kichula; Jielin Wang; Ji He; Paul J Norman; Faming Zhu
Journal:  Front Immunol       Date:  2021-04-30       Impact factor: 7.561

2.  Allele imputation for the killer cell immunoglobulin-like receptor KIR3DL1/S1.

Authors:  Genelle F Harrison; Laura Ann Leaton; Erica A Harrison; Katherine M Kichula; Marte K Viken; Jonathan Shortt; Christopher R Gignoux; Benedicte A Lie; Damjan Vukcevic; Stephen Leslie; Paul J Norman
Journal:  PLoS Comput Biol       Date:  2022-02-22       Impact factor: 4.475

3.  Association analysis of KIR/HLA genotype with liver cirrhosis, hepatocellular carcinoma, and NUC freedom in chronic hepatitis B patients.

Authors:  Satoru Joshita; Masao Ota; Hiroyuki Kobayashi; Shun-Ichi Wakabayashi; Yuki Yamashita; Ayumi Sugiura; Tomoo Yamazaki; Eiji Tanaka; Takeji Umemura
Journal:  Sci Rep       Date:  2021-11-02       Impact factor: 4.379

4.  Associations of Genes for Killer Cell Immunoglobulin-like Receptors and Their Human Leukocyte Antigen-A/B/C Ligands with Abdominal Aortic Aneurysm.

Authors:  Joanna Dubis; Wanda Niepiekło-Miniewska; Natalia Jędruchniewicz; Maciej Sobczyński; Wojciech Witkiewicz; Norbert Zapotoczny; Piotr Kuśnierczyk
Journal:  Cells       Date:  2021-11-30       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.